EAO-CRC
Early Age Onset
Colorectal Cancer
VIRTUAL Summit
12:00 PM – 2:30 PM EST
April 23, 2020
PUTTING KNOWLEDGE INTO ACTION
Join us on April 23rd for the EAO-CRC VIRTUAL Summit
Early Age Onset
EAO-CRC VIRTUAL SUMMIT™ – WHAT A DAY!
Last updated April 24, 2020 11.38 AM
THANK YOU!
What an incredible afternoon! Who needs Times Square, NYC to hold a Summit? Well, we really would love to get together in person however I have to say all reports point to a very productive, positive event yesterday! We couldn’t have done it without our Co-Chairs, Planning Committee, Faculty, and very generous Sponsors!
For those of you who missed it no worries! You can register to view the recording! We ask you to register simply so we can stay in touch as we look to collaborate going forward on all things EAO-CRC.
Stay tuned to the very end of the Summit. You will learn about the opportunity to get involved in working groups to address the GAPS we have identified to move the needle on EAO-CRC even as COVD-19 continues to affect our world. Colorectal cancer doesn’t stop – even for a pandemic.
We had a great time yesterday, we can’t thank you enough for tuning in and look forward to seeing you on future digital events!
Cindy Borassi
Interim President
Colon Cancer Foundation
AGENDA
SPEAKERS:
- April D. Barry, LSW C-CATODSW PN, Performance Improvement Manager, Department of Health | Bureau of Health Promotion and Risk Reduction, Division of Cancer Prevention and Control
- Cindy R. Borassi, Colon Cancer Foundation
- Renay Caldwell, Director of Navigation and Screening Services, University of South Carolina
- Richard Fahrer, EAO-CRC Patient and Oncology Marketing Director, Patient Solutions, Pfizer Pharmaceuticals
- Whiney Jones, Founder, Colon Cancer Prevention Project
- David Greenwald, MD Director of Clinical Gastroenterology and Endoscopy at Mount Sinai Hospital in New York City, Incoming President, American College of Gastroenterology
- Jordan Karlitz, MD, Assistant Clinical Professor of Medicine and Director, GI Hereditary Cancer and Genetics Program at Tulane
- Len Lichtenfeld, Deputy Chief Medical Officer, American Cancer Society
- Krista Nelson, LCSW OSW-C BCD FAOSW, Program Manager, Quality & Research, Cancer Support Services & Compassion, Providence Cancer Institute & Providence St Joseph Health
- Kimmie Ng, MD, MPH, Associate Professor of Medicine | Harvard Medical School, Director, Young-Onset Colorectal Cancer Center, Director of Clinical Research, Director, GI Biobank and Biospecimen Research, Center for Gastrointestinal Oncology, Dana-Farber Cancer Institute
- José Perea MD, PhD, Surgery Department. Fundación Jiménez Díaz University Hospital and Research Institute, Madrid, SPAIN
- Erin Peterson, EAO-CRC Summit ™ CO-HOST, Communications Director, Colon Cancer Coalition
- Susan K. Peterson, PhD, MPH, Department of Behavioral Science, Division of Cancer Prevention and Population Sciences
- Mark B. Pochapin, MD, Director, Division of Gastroenterology, NYU Langone Medical Center, President, American College of Gastroenterology
- Rebecca Siegel, MPH, Strategic Director, Surveillance Information Services, American Cancer Society
- Zsofia Stadler, MD, Associate Professor, Clinical Director, Clinical Genetics Service, Memorial Sloan Kettering Cancer Center
- Phylicia L Woods, Esq., Phylicia L has a accountDirector, Federal Relations at American Cancer Society Cancer Action Network
- Yi-Qian Nancy You, MD, MHSc, FACS, Department of Surgical Oncology, Division of Surgery, MD Anderson Cancer Center
I invite you to take the time today to register to watch the recording of the Virtual EAO-CRC Summit™ – you won’t regret it.
Please contact us at info@coloncancerfoundation with any questions or concerns.
Cindy R. Borassi
Interim President
Colon Cancer Foundation
AGENDA
12:00 PM – 12:20 PM OPENING REMARKS AND FRAMING THE CONVERSATION
- Cindy R. Borassi, Colon Cancer Foundation
- Renay Caldwell, Director of Navigation and Screening Services, University of South Carolina
- Richard Fahrer, EAO-CRC Patient and Oncology Marketing Director, Patient Solutions, Pfizer Pharmaceuticals
- Erin Peterson, EAO-CRC Summit ™ CO-HOST, Communications Director, Colon Cancer Coalition
12:20 PM – 12:30 PM EMERGING ISSUES, CHALLENGES, AND CHANGING EPIDEMIOLOGY OF EAO-CRC
- Rebecca Siegel, MPH, Strategic Director, Surveillance Information Services, American Cancer Society
12:30 PM – 12:35 PM Q&A
12:35 PM – 1:20 PM IMPACT OF COVID-19 ON EAOCRC
- Introduction: Dr. Len Lichtenfeld, Deputy Chief Medical Officer, American Cancer Society
- Jordan Karlitz, MD, Assistant Clinical Professor of Medicine and Director, GI Hereditary Cancer and Genetics Program at Tulane
- David Greenwald, MD Director of Clinical Gastroenterology and Endoscopy at Mount Sinai Hospital in New York City, Incoming President, American College of Gastroenterology
- Mark B. Pochapin, MD, Director, Division of Gastroenterology, NYU Langone Medical Center, President, American College of Gastroenterology
- Kimmie Ng, MD, MPH, Associate Professor of Medicine | Harvard Medical School, Director, Young-Onset Colorectal Cancer Center, Director of Clinical Research, Director, GI Biobank and Biospecimen Research, Center for Gastrointestinal Oncology, Dana-Farber Cancer Institute
- Zsofia Stadler, MD, Associate Professor, Clinical Director, Clinical Genetics Service, Memorial Sloan Kettering Cancer Center
- Phylicia L Woods, Esq., Federal Relations at American Cancer Society Cancer Action Network
- Yi-Qian Nancy You, MD, MHSc, FACS, Department of Surgical Oncology, Division of Surgery, MD Anderson Cancer Center
TOPICS TO BE COVERED:
Emergency Diagnostic Procedures
Elective Age Appropriate Average Risk Screening
Oncological Treatment Interactions with Novel Covid-19 Therapeutics
Clinical Trials
Ongoing EAO-CRC research programs
Telemedicine in the era of COVID-19
Impact of COVI-19 on genetic testing and family member participation in cascade testing
The impacts of COVID-19 on the cancer care healthcare ecosystem; a policy perspective
1:20 PM – 1:30 PM Q&A
1:30 PM – 1:45 PM ATTENDING TO EMOTIONAL WELLBEING DURING COVID-19
- April D. Barry, L.S.W., M.S.W| Evaluation and Performance Improvement Manager, Department of Health | Bureau of Health Promotion and Risk Reduction, Division of Cancer Prevention and Control
- Krista Nelson, LCSW OSW-C BCD FAOSW, Program Manager, Quality & Research, Cancer Support Services & Compassion, Providence Cancer Institute & Providence St Joseph Health
- Susan K. Peterson, PhD, MPH, Department of Behavioral Science, Division of Cancer Prevention and Population Sciences
1:45 PM – 1:50 PM Q&A
1:50 PM – 2:20 PM INTRODUCTION OF EAO-CRC WORKING GROUPS
- Introduction: Whitney Jones, MD Founder Colon Cancer Prevention Project
-
- Family History Ascertainment in the U.S. (Addressing Gap 1), Zsofia Stadler
- Earliest Possible Diagnosis and Treatment through Timely Recognition of the Symptoms and Signs of Young Adult CRC (Addressing Gap 2), Whitney Jones, Erin Peterson
- Timely, Effective, Quality Of Life and Fertility Preserving State of the Art Treatment (Addressing Gap 3), Yi-Qian Nancy You
- How Did This Happen? Investigating the Causes of Early Onset Colorectal Cancers (EAO-CRC) (Addressing Gap 4), Kimmie Ng, Jose Perea
2:20 PM – 2:25 PM Q&A
2:25 PM – 2:30 PM WRAP UP, NEXT STEPS AND THANKS
INSIGHT
InSiGHT
In The CiTY
The 2021 Biennial Conference of the International Society for Gastrointestinal Hereditary Tumours
May 12-15, 2021
A Meeting for Medical Professionals
The InSiGHT 2021 Jersey City/NYC will be a 3.5 day meeting, similar in structure to previous InSiGHT meetings. This year the event will be held after the EAO-ECR event.
Our planned Plenary Sessions will invite the highest level of peer reviewed abstracts to address key areas. These will include:
- Personal and Familial Risk assessment with a focus on effective Family Health History Ascertainment, cancer prevention, advances in surveillance technologies and clinical protocols;
- Novel germline and somatic genetic mechanisms predisposing to hereditary GI malignancy;
- State of the Art Novel gene discovery including the current science of “missing heritability”;
- Novel genomic based therapies;
- Advances in surgical and endoscopic management of hereditary GI malignancies;
- Challenging clinical case discussions;
- The impact of gene panel testing on the genetic and clinical management of the hereditary GI syndromes;
- Additional sessions will be provided to meet the clinical navigation, optimal quality of life and psychological support needs of affected individuals and their families.
The program will also provide opportunities through peer reviewed content and special invited speakers to explore how InSiGHT can optimally position itself to lead globally on key issues such as promoting clinical awareness,education and research on the hereditary GI syndromes. How will we actually deliver on our vision and “promise” to fully integrate all of the continents on our planet in our efforts? How can we best provide effectiveenduring mentorship of the next generation of clinicians and scientists who will take on the clinical and scientific challenges of the hereditary GI syndromes? What steps can we take, as a global organization, to secure sustainability and growth? We will also tackle a very special issue; over 20 years after the cloning of the DNA mismatch repair (MMR) genes, how can InSiGHT rekindle an active relationship with big science including, of course genomics, genetics, and epigenetics to help us advance our collective understanding of the biology of the hereditary GI malignancy syndromes? This is essential to attract “the best and the brightest” of future generations to our scientific and clinical arena.
Registration to attend the event is for healthcare professionals
For more information and to register please click here: https://www.insight2021.org/
InSIGHT CALL FOR ABSTRACTS
ABSTRACT SUBMISSION
IS NOW OPEN
Deadline:
Monday, November 2, 2020, 11:59 PM ET
Notification of Results:
January 11, 2021
These dates are subject to change
Submission Instructions
Abstracts must including title, authors, affiliations and abstract body and may include a table and/or figure.
Please click below for important information and guidelines for your submission.
NEW in 2021- Video Abstracts will be accepted.
For more information on abstract submission click here: https://www.insight2021.org/call-for-abstracts
2020 SUMMIT SPONSORS
| Registration Fees | Early Bird | Regular |
|---|---|---|
| Early Bird Physicians (MDs, PhDs and DOs) | 230.00 | 265.00 |
| Early Bird NPs/PAs/RNs | 200.00 | 230.00 |
| Early Bird Residents, Fellows & Other Healthcare Professionals | 135.00 | 155.00 |
| Patient/Survivor Advocate | 65.00 | 65.00 |
| Industry Representative | 475.00 | 540.00 |
| Breakfast with the Expert | 25.00 (PRIOR RSVP/TICKET PURCHASE REQUIRED) | 30.00 (PRIOR RSVP/TICKET PURCHASE REQUIRED) |
| EAO-CRC Champion Luncheon | 75.00 (PRIOR RSVP/TICKET PURCHASE REQUIRED) | 75.00 (PRIOR RSVP/TICKET PURCHASE REQUIRED) |
2020 SUMMIT SCHEDULE
| Wedesday, April 22, 2020 – 3:00 M – 6:00 PM | Registration |
| Wednesday, April 22 – 4:00 PM – 6:00 PM | Optional Working Groups According to GAPS |
| Wednesday, April 22 – 6:00 – 8:30 PM | Dinner on your own |
| Wednesday, April 22 – 6:00 – 8:30 PM | Planning Committee Dinner (Closed Session) |
| Thursday, April 23, 2020 – 7:00 AM – 7:50 AM | Registration and Chef’s Breakfast |
| Thursday, April 23, 2020 – 7:00 AM – 7:50 AM | Breakfast with the Expert (Reservation required) |
| Thursday, April 23, 2020 – 8:00 AM – 8:30 AM | Framing the Conversation: Strategic Challenges in Current Medical Care that Contribute to Young Adult Colorectal Cancer (CRC) Incidence and Mortality. |
| Thursday, April 23, 2020 – 8:30 AM – 9:15 AM | SESSION I: The Dimensions of the EAO-CRC Problem: Target Item: Accurate, Regular, Up To Date Measurement of Key Metrics Describing the Early Age Onset Colorectal Cancer Public Health Crisis. |
| Thursday, April 23, 2020 – 9:15 AM –10:15 AM | SESSION II: Family History Ascertainment In The U.S. (Addressing Gap 1) What Steps are Needed to Improve the Well Documented Less Than Optimal Status of This Situation? What is Our Best Information on the Documentation of Cancer Family History in Primary Care? What are the Key Elements Required for Success? |
| Thursday, April 23, 2020 – 10:15 AM – 10:45 AM | Networking, Coffee, and Poster Viewing Break |
| Thursday, April 23, 2020 – 10: 55 AM – 11:55 AM | SESSION III: Earliest Possible Diagnosis and Treatment Through Timely Recognition of the Symptoms and Signs of Young Adult CRC (Addressing Gap 2) |
| Thursday, April 23, 2020 – 11:55 – 1:00 PM | EAO-CRC CHAMPION Luncheon |
| Thursday, April 23, 2020 – 1:10 PM – 2:10 PM | SESSION IV: Timely, Effective, Quality Of Life and Fertility Preserving State of the Art Treatment (Addressing Gap 3) |
| Thursday, April 23, 2020 – 2:10 PM 3:10 PM | SESSION V: How Did This Happen? Investigating the Causes of Early Onset Colorectal Cancers (EAO-CRC) (Addressing Gap 4) |
| Thursday, April 23, 2020 – 3:10 PM – 3:30 PM | Networking, Coffee, and Poster Viewing Break |
| Thursday, April 23, 2020 – 3:30 PM – 4:30 PM | Afternoon KEYNOTE |
| Thursday, April 23, 2020 – 4:30 PM – 5:00 PM | Action Plan Consensus Building |
| Thursday, April 23, 2020 – 5:00 PM – 5:30 PM | Abstract awards, next steps, EAOCRC Group Photo |
| Thursday, April 23, 2020 – 5:30 PM Summit Adjourned | |
| Thursday, April 2020 – 5:30 PM – 7:00 PM | Reception immediately following meeting adjournment |
SUMMIT CO-DIRECTORS
Jordan Karlitz,MD
SUMMIT CO-CHAIR
Assistant Clinical Professor of Medicine and Director, GI Hereditary Cancer and Genetics Program at Tulane
Susan K. Peterson, PhD, MPH
SUMMIT CO-CHAIR / ABSTRACT CHAIR
Department of Behavioral Science, Division of Cancer Prevention and Population Sciences
Zsofia Stadler, MD
SUMMIT CO-CHAIR
Clinical Laboratory Investigator, The Kenneth Offit Laboratory, Memorial Sloan Kettering Cancer Center
Yi-Qian Nancy You, MD, MHSc, FACS
SUMMIT CO-CHAIR
Department of Surgical Oncology, Division of Surgery, MD Anderson Cancer Center
COURSE PLANNING COMMITTEE
Andrew Albert, MD, MPH
Planning Committee Member
Medical Director - Digestive Health Program Advocate Illinois Masonic Medical Center
Cindy R. Borassi
Planning Committee Member
Executive Director, Colon Cancer Foundation
Jennifer Butler
Planning Committee Member
Member, Board of Directors
Colon Cancer Foundation
Andrea Cercek, MD
Planning Committee Member
Memorial Sloan Kettering Cancer Center
Zana Correa, NP
Planning Committee Member
Memorial Sloan Kettering Cancer Center
Heather Dacus, DO, MPH
Planning Committee Member
Director, Bureau of Cancer Prevention and Control, New York State Department of Health
James T. D’Olimpio, MD, ACP, FAAHPM
Planning Committee Member
Director of Supportive/Palliative Oncology, Northwell Heath Cancer Institute, Assistant Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Robin Dubin, MBA
Planning Committee Member
Co-founder/Executive Director at AliveAndKickn
Cathy Eng, MD, FACP, FASCO
Planning Committee Member
Vanderbilt-Ingram Cancer Center
David H. Johnson Chair in Surgical and Medical Oncology
Vice-Chair, SWOG GI Committee
Institutional PI, SWOG
Professor of Medicine, Hematology and Oncology
Co-Director, GI Oncology
Co-Leader, Gastrointestinal Cancer Research Program
Heather Hampel, MS, LGC
Planning Committee Member
Associate Director, Division of Human Genetics
Associate Director, Biospecimen Research
Professor, Internal Medicine
Licensed Genetic Counselor
The Ohio State University Comprehensive Cancer Center
Whitney Jones, MD
Planning Committee Member
Founder, Colon Cancer Prevention Project
Matthew Kalady, MD
Planning Committee Member
Matthew F. Kalady, MD, FACS, FACRS; Professor of Surgery, and Vice-Chairman
Department of Colorectal Surgery
Director, Weiss Center for Hereditary Colorectal Neoplasia
Co-Director, Comprehensive Colorectal Cancer Program
James Church and Edward DeBartolo Jr. Family Endowed Chair in Colorectal Surgery
Cleveland Clinic, Cleveland, OH
Krista Nelson, LCSW OSW-C BCD FAOSW
Planning Committee Member
Oncology Social Worker
Program Manager, Quality & Research, Cancer Support Services & Compassion
Providence Cancer Institute & Providence St Joseph Health
Kimmie Ng, MD
Planning Committee Member
Founding Director of the Young-Onset Colorectal Cancer Center, and Director of Clinical and Biospecimen Research in the Center for Gastrointestinal Oncology
Dr. José Perea MD, PhD
Planning Committee Member
Surgery Department. Fundación Jiménez Díaz University Hospital and Research Institute. Madrid, SPAIN.
Erin Peterson
Planning Committee Member
Communications Director
Colon Cancer Coalition
Mary B. Strong, MA
Planning Committee Member
Assistant Vice President, Continuing Medicial Education, Northwell Health
Ronit Yarden, Ph.D. MHSA
Planning Committee Member
Senior Director of Medical Affairs
Colorectal Cancer Alliance
EAO-CRC SUMMIT™ OBJECTIVES
This event will bring together leading clinicians, scientists as well as early age onset (EAO) colorectal cancer (CRC) survivors and caregivers from across the country and internationally. The program will provide extensive opportunities for participants to advance their understanding of the rapidly increasing incidence of rectal and colon cancer among young adults under 50 years of age in the U.S. and abroad.
This groundbreaking program will, for a sixth consecutive year, provide all participants the opportunity to hear and question leading clinicians and researchers on the lifesaving potential of timely clinical risk assessment / family cancer health history; earliest possible stage diagnosis, optimal, fertility preserving clinical care, as well as the latest information regarding national and international EAO CRC incidence trends, pathogenesis, and genetics. In addition, this year’s program will present a “Research in Progress” segment providing an update on currently NCI funded and planned EAO CRC research projects from across America and Europe.
Again this year, important Keynote Sessions based on needs-assessments from our survivor community will address challenging issues such as EAO-CRC Focused Survivorship Programs: How Are They Measuring Up?, specifically requested by our Young Adult CRC Survivor Program Advisory Group.
The EAO-CRC SUMMIT™ will include lectures, optional working groups and panel discussions designed to advance the “state-of-the-science” addressing EAO-CRC. Our faculty will once again be world class speakers representing leading academic medical centers with major additional inspiring programmatic contributions from the Early Age Onset Colorectal Cancer Survivor Community of the United States and beyond.
EAO-CRC SUMMIT™ EDUCATIONAL OBJECTIVES
- Provide an expert review of the latest published information on the increasing incidence and mortality associated with Early Age Onset Colorectal Cancer in the United States and around the globe
- Provide an evidence-based framework for reducing risk, increasing early stage diagnosis and improving treatment and outcomes for young adult colorectal cancer patients.
- Review the State-of-the-Science regarding the known and possible causes of the increasing incidence of EAO-CRC including alterations in our food and water supply, the contribution of novel germline genetic factors and etiologic clues based on the molecular biology of EAO-CRC cancers.
- Define the “Gaps” in our current understanding of Early Age Onset Colorectal Cancer in order to set our clinical and research priorities and develop a strategic plan to reduce EAO-CRC incidence and mortality.
SPONSORSHIP OPPORTUNITIES
The sponsors of the EAO-CRC Summit make it possible for us to build public awareness of colorectal cancer (CRC) including hereditary colorectal cancer and the importance of timely screening and prevention. Their support also allows us to help sponsor prevention programs in New York City including screening efforts for the uninsured and innovative translational research projects focused on early age onset of colorectal cancer.
As a sponsor of the Summit you have the opportunity to reach thousands who join us each year to raise awareness of this deadly and yet preventable disease.
If you are interested in joining our community of Sponsors, please contact Sandra Vassos at 914.305.6674.
PLANNED PRESENTATIONS AND INVITED FACULTY INCLUDE
CRC 2019 BROCHURE
THURSDAY, MAY 2, 2019
7:00 AM – 8:00 AM REGISTRATION AND BREAKFAST
8:00 AM – 8:30 AM FRAMING THE CONVERSATION: STRATEGIC CHALLENGES IN CURRENT MEDICAL CARE THAT CONTRIBUTE TO YOUNG ADULT COLORECTAL CANCER (CRC) INCIDENCE AND MORTALITY. SURVIVOR TESTIMONIALS UNDERSCORE OPPORTUNITIES FOR IMPROVEMENT IN THE PREVENTION AND CARE OF YOUNG ADULT COLORECTAL CANCER.
- Chelsea Boet,Sarah Debord, Kevin Hays, Kim Newcomer, Susan Pfau, Eric Reddy, Valarie Schlosser, Diana Sloan, Denelle Suranski, Tabitha Trent, Wes Hensel
- Opening Remarks: Richard R. Barakat, MD, Physician-in-Chief and Director, Northwell Health Cancer Institute
- How the Survivor Testimonials Framed Today’s Program: Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation
- Housekeeping: Cindy R. Borassi, Colon Cancer Foundation
8:30 AM – 9:35 AM SESSION I: THE DIMENSIONS OF THE EAO-CRC PROBLEM: TARGET ITEM: ACCURATE, REGULAR, UP TO DATE MEASUREMENT OF KEY METRICS DESCRIBING THE EARLY AGE ONSET COLORECTAL CANCER PUBLIC HEALTH CRISIS.
8:30 AM – 8:40 AM
- Overview of Global EAO-CRC Incidence Patterns and Trends
- Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation
8:40 AM – 8:50 AM
- Overview of United States EAO-CRC Incidence Patterns and Trends
- Rebecca L. Siegel, MPH, American Cancer Society
8:50 AM – 9:00 AM
- Utilization of Detailed Centers for Disease Control (CDC) Cancer Registry Data in the Age of Genomic Medicine
- Jordan Karlitz, MD, FACG Tulane University School of Medicine (VIA VIDEO CONFERENCING)
9:00 AM – 9:10 AM
- Overview of European Cancer Registries Data Resources on EAO-CRC
- Irit Ben-Aharon, MD, PhD, Rambam Health Care Campus, Haifa, Israel, European Organisation for Research and Treatment of Cancer (EORTC)
9:10 AM – 9:20 AM
- Survey of Young Onset Patients, Survivors, and Caregivers: Self-Reported Clinical, Psychosocial, Financial and Quality of Life Experiences.
- Ronit Yarden, Ph.D. MHSA, Colorectal Cancer Alliance
9:20 AM – 9:35 AM
- Q&A Panel Discussion – Strategic Plan Development
9:35 AM – 9:50 AM
- Networking, Coffee, Poster Viewing Break
9:50 AM – 11:35 AM SESSION II: FAMILY HISTORY ASCERTAINMENT IN THE U.S. (ADDRESSING GAP 1) WHAT STEPS ARE NEEDED TO IMPROVE THE WELL DOCUMENTED LESS THAN OPTIMAL STATUS OF THIS SITUATION? WHAT IS OUR BEST INFORMATION ON THE DOCUMENTATION OF CANCER FAMILY HISTORY IN PRIMARY CARE? WHAT ARE THE KEY ELEMENTS REQUIRED FOR SUCCESS.
Moderator: Gregory Feero, MD, PhD, Maine Dartmouth Family Medicine Residency, Augusta, ME; Geisel School of Medicine at Dartmouth, Hanover, NH
9:50 AM – 10:10 AM
- Electronic Health Records (EHR) and family cancer history ascertainment. The path forward?
- Gregory Feero, MD, PhD, Maine Dartmouth Family Medicine Residency, Augusta, ME; Geisel School of Medicine at Dartmouth, Hanover, NH
10:10 AM – 10:25 AM
- Review of National Colorectal Cancer Roundtable (NCCRT) Family Health History Early Age Onset Colorectal Cancer (EAO-CRC) Task Group Progress and Overview of the NCCRT Risk Assessment and Screening Toolkit to Detect Familial, Hereditary and Early Onset Colorectal Cancer and next steps for dissemination and implementation
- Dennis Ahnen, MD, AGAF, FACG, University of Colorado School of Medicine, Gastroenterology of the Rockies
10:25 AM – 10:40 AM
- Implementation plan for 2018 American Cancer Society recommendations (and rationale) for screening for the early detection of colorectal cancer.
- Robert A. Smith, PhD, American Cancer Society
10:40 AM – 10:50 AM
- Strategies for Addressing Early Onset CRC: An NCCRT Report
- Jan Lowery, Colorado Center for Personalized Medicine
10:50 AM – 11:00 AM
- Detecting Unaffected Individuals with Lynch Syndrome (DUAL).
- Sayoni Lahiri, MS, CGC, UT Southwestern Medical Center
11:00 AM – 11:10 AM
- Prevalence of Advanced Colorectal Polyps Among First Degree Relatives of EOCRC patients
- Christine L. Sardo Molmenti, PhD, MPH Feinstein Institute for Medical Research, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
11:10 AM – 11:15 AM
- Integrating education on the importance of family health history ascertainment and earliest possible diagnosis into the entire continuum of medical and specialty education from medical school through Board Certification, CME and Recertification.
- Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation
11:15 AM – 11:30 AM
- Q&A Panel Discussion – Strategic Plan Development
11:30 AM – 12:15 PM
LUNCH
12:15 PM – 1:20 PM SESSION III: EARLIEST POSSIBLE DIAGNOSIS AND TREATMENT THROUGH TIMELY RECOGNITION OF THE SYMPTOMS AND SIGNS OF YOUNG ADULT CRC (ADDRESSING GAP 2)
Moderator: Whitney Jones, MD, Clinical Professor of Medicine, University of Louisville
12:15 PM – 12:25 PM
- A review of the published data documenting delays in diagnosis and the consequences in terms of later stage diagnosis and poorer outcomes
- Whitney F. Jones, MD, Gastro & Endo Associate
12:25 PM – 12:35 PM
- Overview of the continuum of providers who interact with patients prior to and up to a diagnosis
- Chelsea Boet, MD, Spectrum Health Medical Group
12:35 PM – 12:45 PM
- Lessons Learned: What have we learned from past public health success stories?
- Jennifer Brown, PhD, NYC Department of Health & Mental Hygiene
12:45 PM – 12:55 PM
- Lessons Learned: What have we learned from past public health success stories?
- Tony Foleno, Senior Vice President, Strategy & Evaluation, Ad Council; President, Society for Health Communication
12:55 PM – 1:05 PM
- Introduction of the EAO-CRC National Clinical Alert and Symptoms and Signs Index
- Andrew Albert, MD, MPH, Chicago Gastro LLC.
- Erin Peterson, Colon Cancer Coalition
- Provider Education Outreach Initiatives
- Patient Awareness and Advocacy Initiatives
1:05 PM – 1:20 PM
- Q&A Panel Discussion – Strategic Plan Development
1:20 PM – 2:45 PM SESSION IV: TIMELY, EFFECTIVE, QUALITY OF LIFE & FERTILITY PRESERVING STATE OF THE ART TREATMENT (ADDRESSING GAP 3)
1:20 PM – 1:30 PM
- Updates on Current Medical Oncology Approaches to Young-Onset CRC
- Andrea Cercek, MD, Memorial Sloan Kettering Cancer Center
1:30 PM – 1:40 PM
- Optimal Preservation of Fertility
- Nicole Noyes MD, Reproductive Endocrinologist, Northwell Health
1:40 PM – 1:50 PM
- Novel Approaches to Metastatic Mismatch Repair (MMR) deficient and Microsatellite Stable (MSS) metastatic Colorectal Cancer
- Cathy Eng, MD, FACP, FASCO, The University of Texas MD Anderson Cancer Center
1:50 PM – 2:00 PM
- From “Bench to Bedside” CRC Experimental Therapeutics and Phase I & II Trials. What’s New & What’s Next?
- Wasif M. Saif, MD, MBBS Northwell Health Cancer Institute
2:00 PM – 2:10 PM
- GAPS in providing Palliative Care and the cost benefit ratio for hospital systems
- James T. D’Olimpio, MD, FACP, FAAHPM North Shore University Hospital
2:10 PM -2:20 PM
- Q&A Panel Discussion
2:20 PM – 2:35 PM
- Identifying the Key Elements of a Center for Early Age Onset Colorectal Cancer – Panel Discussion
- Eric Reddy, Stage IV Colorectal Cancer Survivor
- Andrea Cercek, MD, Memorial Sloan Kettering Cancer Center
- Zana Correa, NP, Memorial Sloan Kettering Cancer Center
- Kimmie NG, MD, MPH, Dana-Farber Cancer Institute
- Karen Fasciano, PsyD, Dana-Farber Cancer Institute
- Christine Louise S. Molmenti, MPH, PhD Feinstein Institute for Medical Research/ Northwell Health
- Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation
- Krista Nelson, LCSW OSW-C BCD FAOSW, Providence Cancer Institute, Providence St Joseph Health
2:35 PM – 2:45 PM
- Q&A Panel Discussion – Strategic Plan Development
2:45 PM – 3:00 PM
- Networking, Coffee, Poster Viewing Break
3:00 PM – 5:35 PM SESSION V: HOW DID THIS HAPPEN? INVESTIGATING THE CAUSES OF EARLY ONSET COLORECTAL CANCERS (EAO-CRC) (ADDRESSING GAP 4)
The Genetics of Heritable CRC: What’s New and Important to Know Regarding the Genetics of EAO-CRC? Moderators: Professors Kauff & Weber
Moderator(s): Noah D. Kauff, MD, Duke Cancer Institute, Duke University Health System and Thomas K. Weber, MD, FACS, Northwell Health, Colon Cancer Foundation
3:00 PM – 3:10 PM
- Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients with Early-Onset Colorectal Cancer.
- Heather Hampel, MS, LGC, The Ohio State University Comprehensive Cancer Center
3:10 PM – 3:20 PM
- Molecular subtype of colorectal cancer associated with early age of onset
- Xavier Llor, MD, PhD, Yale University School of Medicine Smilow Cancer Center
3:20 PM – 3:30 PM
- Germline Genetic Variants Associated with Young-Onset Colorectal Cancer: The MSKCC Experience
- Zsofia K. Stadler, MD Clinical Director, Clinical Genetics Service, Memorial Sloan Kettering Cancer Center
3:30 PM – 3:40 PM
- Germline Genetic Features of Young Individuals with Colorectal Cancer
- Elena M. Stoffel MD MPH, Director Cancer Genetics Clinic, University of Michigan
3:40 PM – 3:50 PM
- Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
- Matthew B. Yurgelun MD, Dana-Farber Cancer Institute, Harvard Medical School
What is driving the increases in EAO-CRC, 80 + % of which is NOT related to the Named Hereditary CRC Syndromes ?
3:50 PM – 4:00 PM
- Obesity, Sedentary Behaviors, and Early-Onset CRC, Yin Cao, MPH, ScD, MPH, Washington University School of Medicine
4:00 PM – 4:10 PM
- New Suspects: Diet, Microbiome, Immunology and Cancer Risk, Semir Beyaz, PhD, Cold Spring Harbor Laboratories
4:10 PM – 4:20 PM
- New Research Information: Current Efforts to investigate the causes of increases in MSS CRC among young adults.
- The United States:
- Current NCI Funded Investigations into the Causes of Early Age Onset Colorectal Cancer:
- The United States:
-
-
-
-
- Colorectal Cancer Risks in People < 50 Years of Age NIH (RO3): Epidemiology, Richard Hayes, DDS, PhD, MPH, The Cancer Institute at NYU Langone
-
-
-
4:20 PM – 4:30 PM
- Presentation Early Life Risk Factors and Risk of Colorectal Neoplasia, Kana Wu, MD, PhD, Harvard T.H. Chan School of Public Health, Dana-Farber, Harvard Cancer Center
4:30 PM – 4:40 PM
- The European Union: Funded Investigations
- European Organization for Research and Treatment of Cancer (EORTC): Young Onset CRC: Causation, Treatment and Outcomes, Irit Ben-Aharon, MD, PhD, Rambam Health Care Campus, Haifa, Israel European Organisation for Research and Treatment of Cancer
4:40 PM – 4:50 PM
- European study of Early-onset Colorectal Cancer (EUREOC): A Collaborative Study of the Biology of Young Onset CRC, Jose Perea, MD, PhD, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
4:50 PM – 5:00 PM
- In Development: CRAYON: ColoRectal Cancer in Adults at Young ONset: New York City Based Prospective Accrual Study of Young Onset Colorectal Cancer
- Steven H. Itzkowitz MD, Icahn School of Medicine at Mount Sinai
- Steven H. Itzkowitz MD, Icahn School of Medicine at Mount Sinai
5:00 PM – 5:10 PM
- The Beyond CRC Project
- Kimmie Ng, MD, MPH, Dana-Farber Cancer Institute
5:10 PM – 5:20 PM
- The Search for Novel Drivers of Young Onset MSS CRC: An overview of current NIH, CDC and ACS efforts, Thomas K. Weber, MD, FACS, Northwell Health
5:20 PM – 5:30 PM
- Report back from Denver EAO CRC Research Meeting, Heather Hampel, The Ohio State University Comprehensive Cancer Center
5:30 PM – 5:45 PM
- Discussion and “Next Steps”
5:45 PM – 6:45 PM
- Poster Session and Reception
FRIDAY, MAY 3, 2019
8:00 AM – 9:00 AM REGISTRATION AND BREAKFAST WITH THE DOCTORS (Krista Nelson and Karen Fasciano)
9:00 AM – 9:05 AM WELCOME BACK!
Course Co-Director Wasif M. Saif, MD, MBBS, Northwell Health Cancer Institute
9:00 AM – 9:05 AM HOUSEKEEPING
Course Co-Director Susan Peterson, PhD, MPH, The University of Texas MD Anderson Cancer Center
9:05 AM – 10:05 AM
SESSION VI: PALLIATIVE CARE: WHY EARLY IS BEST. (INCLUDING GUIDANCE, SUPPORT AND RESOURCES TO PATIENTS AND CAREGIVERS DURING THEIR TREATMENT JOURNEY/CONTINUUM OF CARE. (ADDRESSING GAP 5)
James T. D’Olimpio, MD, FACP, FAAHPM North Shore University Hospital
Sarah Debord, Colon Cancer Coalition
Andy Esch, MD, MBA, Palliative Care and Survivorship of Western New York
Karen Fasciano, PsyD, Dana-Farber Cancer Institute
Susan Pfau,
Krista Nelson, LCSW OSW-C BCD FAOSW,
10:05 AM – 10:25 AM
SESSION VI EPIGENETICS AND ITS FUTURE ROLE IN THE DIAGNOSIS AND TREATMENT OF INDIVIDUALS MORE SPECIFICALLY AND ACCURATELY
- Richard Boland, MD, AGAF, UC San Diego
10:25 AM – 10:45 AM
- Networking, Coffee, Poster Viewing Break
10:45 AM – 11:20 PM
STRATEGIC PLANNING SESSION (BREAKOUT GROUPS ACCORDING TO GAP)
- Data, accurate, regular to measurement of key metrics
- Family History Ascertainment
- Earliest Possible Stage Diagnosis
- Development of centers of excellence dedicated to the treatment of EAO CRC patients and caregivers
- Research into the causes of early onset colorectal cancers
11:20 AM – 11:45 PM
REPORT BACK FROM STRATEGIC ACTION PLAN BREAKOUT GROUPS
THE EAOCRC PLEDGE
11:45 PM – 12:15 PM
ABSTRACT POSTER SESSION AWARDS
CLOSING REMARKS
INVITED FACULTY
This year the Summit will feature presentations from EAO-CRC survivors, caregivers clinicians from the nation’s leading cancer centers, and representatives of CRC advocacy organizations including
| American Cancer Society Association of Oncology Social Work The Cancer Institute at NYU Langone Chicago Gastro LLC. Cold Spring Harbor Laboratories Columbia University Colorectal Cancer Alliance Colon Cancer Coalition Colon Cancer Prevention Project Dana-Farber Cancer Institute Duke Cancer Center Harvard Cancer Institute Dartmouth Geisel School of Medicine Donald and Barbara Zucker School of Medicine at Hofstra/Northwell European Orgnisation for Research and Treatment of Cancer (EOCRT) Feinstein Institute for Medical Research European Organization for Research and Treatment of Cancer Fox Chase Cancer Center Fundacion Jimenez Diaz University Hospital Georgia State University Harvard Medical School Harvard T.H. Chan School of Public Health | Institute for Biomedical Sciences Icahn School of Medicine at Mt. Sinai Hospital Indiana University School of Medicine Jackson Laboratory for Genomic Medicine Kaiser Permanente Laura and Isaac Perlmutter Cancer Center MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center The Kenneth Offit Lab Memorial Sloan Kettering Cancer Center Michael’s Mission Midwest Gastroenterology Associates Mt. Sinai Medical Center National Institutes of Health (NIH) National Colorectal Cancer Roundtable (NCCRT) the Never Too Young Coalition New York Presbyterian/Herbert Irving Comprehensive Cancer Center New York Citywide Colon Cancer Control Coalition New York University School of Medicine North Shore University Hospital | Northwell Health Northwell Health Cancer Institute The Ohio State University Comprehensive Cancer Center Palliative Care and Survivorship of Western New York Ranbam Health Care Campus Regenstrief Institute, Inc. Spectrum Health Medical Group Tufts University Medical Center Tulane University School of Medicine University of Chicago Medicine Comer Children’s Hospital, University of Colorado School of Medicine UT Southwestern Medical Center UCSD School of Medicine – San Diego University of Michigan Rogel Cancer Center,University of Missouri School of Medicine Washington University School of Medicine World Health Organization Yale New Haven Hospital. |
| Dennis J. Ahnen MD AGAF FACG | University of Colorado School of Medicine |
| Andrew Albert, MD, MPH | Chicago Gastro, LLC |
| Richard Barakat, MD | Northwell Health Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell |
| Irit Ben-Aharon, M, PhD | Ranbam Health Care Campus, European Organisation for Research and Treatment of Cancer (EOCRT) |
| Semir Beyaz, PhD | Cold Spring Harbor Laboratories |
| Chelsea Boet, MD | Spectrum health Medical Group |
| C. Richard Boland MD AGAF | UCSD School of Medicine, San Diego |
| Anne Carlson | Colon Cancer Coalition |
| Yin Cao, MPH, ScD, MPH | Washington University School of Medicine |
| Andrew Cercek, MD | Memorial Sloan Kettering Cancer Center |
| Zana Correa, NP | Memorial Sloan Kettering Cancer Center |
| James T. D’Olimpio, MD, FACP, FAAHPM | North Shore University Hospital |
| Sarah Debord | Colon Cancer Coalition |
| Emily Edelman, MS, CGC | The Jackson Laboratory |
| Cathy Eng, MD, FACP, FASCO | The University of Texas MD Anderson Cancer Center |
| Andrew W. Eshe, MD, MBA | Center to Advance Palliative Care |
| Greg Feero, MD | National Human Genome Research Institute |
| Heather Hampel MS LGC | The Ohio State University Comprehensive Cancer Center |
| Richard Hayes, DDS, PhD, MPH | The Cancer Insitute at NYU Langone |
| Stacy Hurt, MHA, MBA | Colon Cancer Coalition |
| Steven H. Itzkowitz, MD | Icahn School of Medicine at Mount Sinai |
| Whitney Jones MD | Midwest Gastroenterology Associates, Colon Cancer Prevention Project |
| Jordan Karlitz, MD, FACG | Tulane University School of Medicine |
| Noah Kauff, MD | Duke Cancer Center |
| Maureen Killackey, MD | New York Presbyterian/Herbert Irving Comprehensive Cancer Center |
| Sayoni Lahiri, MS, CGC | UT Southwestern Medical Center |
| Caleb Levell | National Colorectal Cancer Roundtable, American Cancer Society |
| Xavier Llor, MD, PhD | Cancer Genetics and Prevention Program, Yale New Haven Hospital |
| Jan Lowry, PhD, MPH | Colorado School of Public Health |
| Jonathan Mitchem, MD | University of Missouri School of Medicine |
| Christine Louise S. Molmenti PhD | Feinstein Institute for Medical Research, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell |
| Krista Nelson, LCSW, OSW-C, BCD, FAOSW | Association of Oncology Social Work |
| Nicole Noyes, MD | Northwell Health |
| Jose’ Perea MD PhD | Fundacion Jimenez Diaz University Hospital |
| Erin Peterson | Colon Cancer Coalition |
| Susan Peterson PhD, MPH | The University of Texas MD Anderson Cancer Center |
| Wasif Saif, MD | Northwell Health Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell |
| Rebecca L. Siegel, MPH | American Cancer Society |
| Zsophia Stadler MD | Memorial Sloan Kettering Cancer Center, The Kenneth Offit Lab |
| Elena Stoffel, MD | University of Michigan Rogel Cancer Center |
| Thomas K. Weber MD FACS | Director of Surgical Oncology; Northwest Region at Northwell Health |
| Ronit Yarden, PhD, MHSA | Colorectal Cancer Alliance |
| Mathew B. Yurgelun, MD | Dana-Farber Cancer Insitute, Harvard Medical School |
| Kana Wu, MD, PhD, MPH | Harvard T.H. Chan School of Public Health, Dana-Farber Cancer Institute, Harvard Medical School |
CME INFORMATION
The Colon Cancer Foundation is seeking accreditation for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physicians: AMA PRA Category 1 CreditsTM number to be determined.
Nurses: ANCC contact hours to be determined.
Physician Assistants: AAPA Category 1 CME credit for activities to be determined.
ABSTRACTS & SCHOLARSHIPS
The EAO-CRC Program Planning Committee invites attendees to submit abstracts for a poster presentation at the sixth annual meeting on April 22 – 23, 2020. Abstracts may describe research or programs, and may have been presented elsewhere.
KEY DATES
Deadline for submission is March 15, 2020. Abstracts should be submitted as an MS Word document to the following email address: abstracts@coloncancerfoundation.org.
March 15, 2020 at 11:59 PM ET
Abstract Submission Deadline
March 22, 2020 at 11:59 ET
Early Bird Registration Deadline
March 30, 2020 at 11:59 ET
Hotel Reservation Deadline
March 30, 2020 at 11:59 ET
Abstract Approval Letters Disseminated
April 19, 2020 at 11:59 PM ET
Abstracts Released on EAO-CRC Meeting Library
April 23, 2020 7:00 AM – 7:30 PM
6th Annual EAO-CRC Summit
ABSTRACT SUBMISSION GUIDELINES
Abstracts should be submitted as an MS Word document to the following email address: abstracts@coloncancerfoundation.org. Abstracts should include a title, and name(s) of all author(s) and their institution or organization affiliation. The name of the presenting author should be underlined. The body of the abstract should not exceed 350 words. See below for guidelines specific to the body of research and program abstracts.
RESEARCH ABSTRACTS Abstracts describing scientific research on early age onset colorectal cancer should organize the content using the following subheadings: Background, Methods, Results, and Conclusions. One data table is permitted per abstract. Illustrations and figures are not permitted. Define all abbreviations. Include the abstract title, full names and institutional affiliations of all authors, and email address of the corresponding author at the top of the abstract. Underline the name of the presenting author. Abstracts must not contain copyrighted material unless permission has been obtained by the author. Indicate at the bottom of the page if the abstract has been presented elsewhere and at what meeting. Submitted abstracts not meeting the above specifications will be returned. Any and all relevant conflicts of interest need to be noted at the bottom of the abstract.
Any questions regarding abstract submission should be directed to abstracts@coloncancerfoundation.org
PROGRAM ABSTRACTS Abstracts describing programs focused on any aspect of early age onset colorectal cancer should organize the content using the following subheadings: Program Objectives, Audience, Program Description, Future Directions. One table is permitted per abstract. Illustrations and figures are not permitted. Define all abbreviations. Include the abstract title, full names and institutional affiliations of all authors, and email address of the corresponding author at the top of the abstract. Underline the name of the presenting author. Abstracts must not contain copyrighted material unless permission has been obtained by the author. Indicate at the bottom of the page if the abstract has been presented elsewhere and at what meeting. Submitted abstracts not meeting the above specifications will be returned. Any and all relevant conflicts of interest need to be noted at the bottom of the abstract.
Any questions regarding abstract submission should be directed to abstracts@coloncancerfoundation.org
POSTER PRESENTATION SESSIONS
Poster presentations will provide an opportunity for interchange of ideas between the presenter and EAO CRC Summit attendees in his/her study. The poster should be outlined so the research can be understood without an oral explanation as a poster may also be viewed when the author is not present.
Poster location to be determined. Posters will be easily accessible and available for viewing for the duration of the EAO CRC Summit including a reception to be held on the evening of April 23.
Set-Up: Will take place on Wednesday, April 22 time TBD. Each poster will be assigned a sequential number. Locate your assigned poster board and mount your poster within the time noted on the instructions received once accepted. Pushpins will be provided in the area by the Moderators.
Format of poster is LANDSCAPE (horizontal).
Regular Poster Size Limitations: TBD
Photos, Charts, and Graphs: Charts, drawings, and illustrations should be similar to those you would use in making PowerPoint slides. If photographs are used, please have them processed with a matte or dull finish.
Contact Information: Please clearly print 1 email address on your poster for attendees to refer to should they have any questions or comments at a time when you are not standing with your poster. If you do not wish to print your own email address, please list another email address for an appropriate contact person for your abstract.
Poster Material: The poster can either be made on 1 sheet (rollup) or in several small sections. Do NOT mount illustrations on heavy cardboard because they may be difficult to keep in position on the poster board.
Take-Down: Will take place on Thursday, April 23, 7:30 PM. Please disassemble your posted materials at the end of the EAO CRC Summit. Any materials left on the poster board at the end of the session will be removed and disposed of.
AWARDS AND JUDGING
As part of the abstract review process the poster review committee will identify the top ranking abstracts. EAO CRC Summit attendees will also have the opportunity to review posters and vote for the People’s Choice Award. The top three abstracts and the People’s Choice Awardee will recognized during the EAO CRC Summit poster session and during the closing remarks/award ceremony.
THE DR. THOMAS K. WEBER, MD, FACS NEXT GENERATION RESEARCH SCHOLAR AWARD
The Colon Cancer Foundation and the EAO-CRC Planning Committee are pleased to announce the The Dr. Thomas K. Weber, MD, FACS Next Generation Research Scholar Award aimed to promote and recognize excellence in research focused on early onset colorectal cancer. This award will provide $2,500 to cover meeting registration, travel and accommodation expenses to the 6th Annual EAO-CRC Summit on April 22-23, 2020 in New York City.
Dr. Thomas Weber was a staunch supporter of young or early career investigators – always the first to encourage them to be big and bold with their ideas. He believed it is imperative that we bring them into the heart of our discussions at the earliest possible stage to ensure progress continues on these most pressing and urgent issues.
As he himself wrote, ” How can we best provide effective enduring mentorship of the next generation of clinicians and scientists who will take on the clinical and scientific challenges.” We are quite certain he meant to include those who will continue to advocate for the patients and caregivers – who will give them a voice.
The Dr. Thomas K. Weber, MD, FACS Next Generation Research Scholar Award Criteria:
The goal of this Award is to recognize excellence in clinical research focused on early age onset colorectal cancer. In providing this award, the CCF seeks to both support and promote EAO-CRC research. The CCF has a special interest in the biology of early age of onset. However, research into other areas of early age onset colorectal cancer (e.g., novel treatments, innovative minimally invasive screening technologies) will also be considered.
WHO SHOULD SUBMIT?
The following are eligible to apply:
Trainees (i.e., postdoctoral fellows, residents, and clinical fellows);
Junior faculty (within one year of first independent faculty appointment); or
Junior genetic counselors (within one year of completion of training).
ACCOMMODATIONS
The Westin Times Square
270 W 43rd St, New York, NY 10036
The Colon Cancer Foundation has reserved a small block of rooms at the The Westin Times Square. Please use the link below to make your reservation. Additional rooms may be available by contacting the hotel directly at (212) 247-0300.
Last Day to Book: Tuesday, March 31, 2020
Special group rate:$299 USD
DONATE
YOU’RE MAKING AN IMPACT
ON COLORECTAL CANCER AND ALL THOSE AFFECTED
LIBRARY
Global Patterns and Trends in Colorectal Cancer
Incidence in Young Adults
The Fifth Annual
EAO-CRC Summit
(2019)
Abstracts
The Fifth Annual
EAO-CRC Summit
(2019)
Agenda
How Nurses Can Support Physicians
in Identifying Colorectal Cancer Risk
(2019)
Videos
Be Alert to the Symptoms
of Colorectal Cancer
(2019)
Videos
The Fifth Annual
EAO-CRC Summit
(2019)
Videos
The Fifth Annual
EAO-CRC Summit
(2019)
Photo Gallery
The Fifth Annual
EAO-CRC Summit
(2019)
Session i Slides
The Fifth Annual
EAO-CRC Summit
(2019)
Session ii Slides
The Fifth Annual
EAO-CRC Summit
(2019)
Session iii Slides
The Fifth Annual
EAO-CRC Summit
(2019)
Session iv Slides
The Fifth Annual
EAO-CRC Summit
(2019)
Session v (part one) Slides
The Fifth Annual
EAO-CRC Summit
(2019)
Session v (part two) Slides
The Fifth Annual
EAO-CRC Summit
(2019)
Session vi Slides
The Fourth Annual
EAO-CRC Summit
(2018)
The Third Annual
EAO-CRC Summit
(2017)
Optimizing Outcomes For EAO-CRC
The Third Annual
EAO-CRC Summit
(2017)
The Third Annual
EAO-CRC Summit
(2017)
The Second Annual
EAO-CRC Summit
(2016)
The First Annual
EAO-CRC Summit
(2015)
Cancer Group Calls for Colorectal Cancer Screening Starting at Age 45
(via New York Times)
Colon and Rectal Cancers Rising in Young People
(via New York Times)